iqvia glp-1 prescriptions q3 2024 semaglutide tirzepatide The Dermatology Digest | The US FDA approves the once-daily oral form of # (Wegovy pill, #NovoNordisk), making it the first oral #GLP1 medicine for Outlook for obesity in 2025:

Anesthesia and glucagon-like peptide-1 receptor agonists: proceed with caution

What started as a diabetes treatment could one day help reshape how we approach inflammatory diseases like arthritis, treating both the symptoms and the root causes at once

As the popularity of GLP-1 medications for type 2 diabetes and obesity continues to skyrocket, patients and doctors report a growing list of side effects

At 5 mg/mL, the 7.5 mg and 10 mg doses exceed a single U-100 syringe (100 units / 1.0 mL) and are split into two injections, while lower doses fit in one shot

What to expect in the first 12 weeks Weeks 14: smaller appetite, earlier fullness, sometimes nausea , bloating , or constipation